|
Updated Analyst Report from Marcel Wijma, Van Leeuwenhoeck Institute
|
10
|
Resverlogix Corp.
|
Feb 02, 2018 11:00AM
|
|
Updated Agenda for next weeks Discovery on Target meeting 9/22 and 9/23
|
8
|
Resverlogix Corp.
|
Sep 16, 2015 03:11PM
|
|
Upcoming Zenith Events
|
4
|
Zenith Epigenetics
|
Feb 18, 2019 01:01PM
|
|
Upcoming RVX presentations, human blood microarray & babbling on FACET analysis
|
6
|
Resverlogix Corp.
|
Jul 24, 2015 04:25PM
|
|
Upcoming Resverlogix and Zenith Events
|
5
|
Resverlogix Corp.
|
Jan 12, 2016 03:31PM
|
|
Upcoming Resverlogix and Zenith Events
|
4
|
Zenith Epigenetics
|
Jan 12, 2016 03:32PM
|
|
Upcoming CVOT results
|
2
|
Resverlogix Corp.
|
Apr 12, 2019 10:08AM
|
|
Upcoming biOasis Non-Human Primate Studies
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 19, 2017 02:05PM
|
|
Upcoming Bioasis Events!
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 11, 2016 10:41PM
|
|
Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
5
|
Zenith Epigenetics
|
Sep 02, 2018 12:42PM
|
|
Two investor conferences May 2
|
6
|
Resverlogix Corp.
|
Apr 30, 2016 05:43PM
|
|
TSX Review
|
2
|
Resverlogix Corp.
|
Mar 12, 2018 12:21PM
|
|
Transferrin targeted nanoparticles containing temozolomide and JQ1 cross BBB in preclinical study to treat glioblastoma
|
|
BIOASIS TECHNOLOGIES INC
|
May 21, 2018 12:19PM
|
|
Toxicities observed with BET pan-inhibition by CPI-0610 and OTX-015
|
6
|
Zenith Epigenetics
|
Mar 24, 2016 11:13AM
|
|
Top-Line, Primary Outcomes, Secondary Outcomes, Exploratory Outcomes, and Alzheimer's/Cognitio...
|
8
|
Resverlogix Corp.
|
Jul 12, 2018 02:37PM
|
|
Top-line vs. Full Detailed Clinical Trial Results
|
5
|
Resverlogix Corp.
|
Aug 28, 2018 03:08PM
|
|
Top Line Mid Year
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 02:39PM
|
|
To those still complaining about flagging violations and removing posts.....
|
6
|
Resverlogix Corp.
|
Jun 23, 2016 10:27AM
|
|
Times and place of Resverlogix and Zenith Special Meetings
|
4
|
Resverlogix Corp.
|
Jun 09, 2015 11:49AM
|
|
Timelines for notice of meeting for AGMs
|
5
|
Resverlogix Corp.
|
Sep 08, 2016 04:36PM
|
